Remarkably, most VEXAS diagnoses in the recent era result from UBA1 testing of patients already followed up for rheumatologic and haematologic disorders even years prior to the actual suspicion, given the very recent discovery of the disease. This evidence concerns the gene UBA1 and hematologic disorder.